Results 221 to 230 of about 1,518,675 (340)
November 13, 2023Date Range: August 1 \u2013 August 31, 2023Themes with the potential to impact vaccine confidence and demand:\u2022 Theme 1: Public health officials are urging eligible individuals to get vaccinated against COVID-19, RSV, and flu and to ...
core
Abstract Background Vancomycin is first‐line treatment for methicillin‐resistant Staphylococcus aureus (MRSA) infections. However, despite guideline recommendations, there is no evidence that targeting vancomycin trough concentrations of ≥15 mg/L in children confers clinical benefit and is associated with vancomycin‐associated nephrotoxicity (VAN ...
Megan R. Nettleton +11 more
wiley +1 more source
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang +9 more
wiley +1 more source
Perspectives on COVID-19 vaccine decision-making in women of reproductive age: A social approach. [PDF]
Hornbach A +3 more
europepmc +1 more source
Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine. [PDF]
Ma C +8 more
europepmc +1 more source
ABSTRACT Co‐administration of COVID‐19 and influenza vaccines has been promoted to improve coverage, but acceptance among healthcare workers (HCWs) remains uncertain. In total, 1238 participants were recruited. Participants were categorized by vaccination pattern including same‐day co‐administration, non‐concurrent vaccination, or single vaccine ...
Yu‐Yin Lin +11 more
wiley +1 more source
Characteristics of COVID-19 vaccine hesitancy in university students: Methodological insights from a syndemic perspective. [PDF]
Yu T, Yuan J, Wang L, Li M.
europepmc +1 more source
Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study
COVID‐19 is associated with an increased incidence of new‐onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ...
Cali Loblundo +4 more
wiley +1 more source

